Abstract
The in vitro susceptibilities of 242 isolates of Serratia marcescens to 17 antibacterial drugs have been determined. Oxolinic acid, nalidixic acid, cefoxitin, and amikacin were the most active drugs. Ampicillin, kanamycin, and cephalothin were among the least active. A 4-year study showed that resistance of S. marcescens to dibekacin, tobramycin, sisomycin, and gentamicin has increased at least one order of magnitude in that period, whereas resistance to amikacin showed but a twofold increase.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Birnbaum J., Stapley E. O., Miller A. K., Wallick H., Hendlin D., Woodruff H. B. Cefoxitin, a semi-synthetic cephamycin: a microbiological overview. J Antimicrob Chemother. 1978 Jul;4(B):15–32. doi: 10.1093/jac/4.suppl_b.15. [DOI] [PubMed] [Google Scholar]
- Cooksey R. C., Bannister E. R., Farrar W. E., Jr Antibiotic resistance patterns of clinical isolates of Serratia marcescens. Antimicrob Agents Chemother. 1975 Apr;7(4):396–399. doi: 10.1128/aac.7.4.396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Greenup P., Blazevic D. J. Antibiotic susceptibilities of Serratia marcescens and Enterobacter liquefaciens. Appl Microbiol. 1971 Sep;22(3):309–314. doi: 10.1128/am.22.3.309-314.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Verbist L., Vandepitte J., Vandeven J. Activity of eight aminoglycosides against isolates of Serratia marcescens from four hospitals. J Antimicrob Chemother. 1978 Jan;4(1):47–55. doi: 10.1093/jac/4.1.47. [DOI] [PubMed] [Google Scholar]